Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy

dc.creatorBernardohanan
dc.creatorLeonardo Maciel Fonseca
dc.creatorMagda Maria Profeta da Luz
dc.creatorAntonio Lacerda Filho
dc.creatorMônica Maria Demas Álvares Cabral
dc.creatorRodrigo Gomes da Silva
dc.date.accessioned2023-05-04T20:39:25Z
dc.date.accessioned2025-09-09T00:47:39Z
dc.date.available2023-05-04T20:39:25Z
dc.date.issued2010-01
dc.description.abstractIntrodução: O objetivo foi avaliar o tratamento combinado da cirurgia citorredutora e quimioterapia intraperitoneal em pacientes com carcinomatose peritoneal secundária ao câncer colorretal, pseudomixoma peritoneal e mesotelioma. Métodos: Foram obtidos dados de 73 pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora (52.1%), pseudomixoma peritoneal (41,1%) ou mesotelioma (6,8%). Foram avaliados o grau de morbidade, a taxa de mortalidade e as taxas de sobrevida após a cirurgia citorredutora e quimioterapia intraperitoneal. Resultados: 41 (56,2%) pacientes do sexo feminino participaram, com média de idade de 50 anos. 39 pacientes (53,4%) foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal. Todos esses receberam Mitomicina C, sendo 16/39 (41%) quimioterapia intraperitoneal hipertérmica (41–42◦C). A morbidade global foi 23,3%, com taxa de mortalidade global de 5,5%. A análise univariada mostrou que câncer colorretal e quimioterapia intraperitoneal (p = .029), transfusão sanguínea (p = .002) e tempo operatório (p = .001) foram associados com complicac¸ões pós-operatórias. Pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 81,3%; 12,5% e 12,5% em 1, 3 e 5 anos, respectivamente. Os pacientes com pseudomixoma peritoneal que foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 84,2%; 77,7% e 77.7% em 1, 3 e 5 anos, respectivamente. Conclusão: O tratamento combinado para carcinomatose peritoneal é seguro quando realizado em centros terciários com experiência no procedimento. Embora mais da metade dos pacientes tenham sido submetidos a quimioterapia intraperitoneal normotérmica após a cirurgia citorredutora completa, os resultados podem ser comparados a de outros centros que utilizam exclusivamente a quimioterapia hipertérmica
dc.format.mimetypepdf
dc.identifier.doi10.1016/j.jcol.2017.11.006
dc.identifier.issn22379363
dc.identifier.urihttps://hdl.handle.net/1843/52817
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofJournal of Coloproctology
dc.rightsAcesso Aberto
dc.subjectProcedimentos Cirúrgicos de Citorredução
dc.subjectNeoplasias Colorretais
dc.subjectQuimioterapia Intraperitoneal Hipertérmica
dc.subjectNeoplasias Peritoneais
dc.subject.otherProcedimentos Cirúrgicos de Citorredução
dc.subject.otherNeoplasias Colorretais
dc.subject.otherQuimioterapia Intraperitoneal Hipertérmica
dc.subject.otherNeoplasias Peritoneais
dc.titlePeritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy
dc.title.alternativeCarcinomatose peritoneal tratada com cirurgia citoreductiva e quimioterapia intraperitonea
dc.typeArtigo de periódico
local.citation.epage178
local.citation.issue2
local.citation.spage172
local.citation.volume38
local.description.resumoIntroduction: To evaluate the combined treatment with cytoreductive surgery and intraperi toneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma. Methods: Data were obtained from 73 patients with peritoneal carcinomatosis arising from colorectal cancer (52.1%), pseudomyxoma peritonei (41.1%) or mesothelioma (6.8%) between 2002 and 2011. We reported the morbidity grade (II, III and IV), mortality and survival rates of the candidates after cytoreductive surgery and intraperitoneal chemotherapy. Results: 41 (56.2%) women participated, and the median age was 50 years. Thirty nine patients (53.4%) underwent complete cytoreductive surgery and intraperitoneal chemotherapy. Patients who underwent a complete cytoreduction received intraperitoneal chemotherapy with mitomycin C, from which only 16/39 (41%) had hyperthermic intraperi toneal chemotherapy (41–42 ◦C). The overall morbidity rate was 23.3% and the grade III/IV complication rate was 12.3%. The overall mortality rate was 5.5%. The univariate analy sis showed that cytoreductive surgery and intraperitoneal chemotherapy (p = .029), a blood transfusion (p = .002) and the operative time (p = .001) were significant for the occurrence of postoperative complications. Patients with peritoneal carcinomatosis from colorectal cancer who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 81.3%, 12.5% and 12.5% at 1, 3 and 5 years, respectively. Patients with peritoneal carcinomatosis from pseudomyxoma peritonei who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 84.2%, 77.7% and 77.7% at 1, 3 and 5 years, respectively Conclusion: The combined treatment for peritoneal carcinomatosis may be performed safely with acceptable morbidity and mortality in a specialized unit setting. Although over half of patients underwent normothermic intraperitoneal chemotherapy, our results were compa rable to results from others centers.
local.identifier.orcidhttps://orcid.org/0000-0002-5970-9570
local.publisher.countryBrasil
local.publisher.departmentMED - DEPARTAMENTO DE CIRURGIA
local.publisher.initialsUFMG
local.url.externahttps://www.thieme-connect.de/products/ejournals/abstract/10.1016/j.jcol.2017.11.006

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy pdfa.pdf
Tamanho:
312.42 KB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição: